The Dominican Republic has concluded 2025 with a significant public health milestone, reporting zero deaths from dengue fever ...

IonQ’s investment thesis is neutral-to-bullish, supported by a full-stack platform strategy and a $1B-plus commercial ...

MicroCloud Hologram Inc. (NASDAQ: HOLO), ("HOLO" or the "Company"), a technology service provider, released learnable quantum spectral filter technology for hybrid graph neural networks. This ...

RedChip Companies will air interviews with Processa Pharmaceuticals, Inc. (Nasdaq:PCSA) and 60 Degrees Pharmaceuticals, Inc. ...

Cybersecurity experts discuss 2026 predictions, highlighting the rise of AI-driven threats and the need for advanced security ...

NeoGenomics, Inc. , a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the appointment of diagnostics and lab services industry veteran John P. "Jack" ...

A toxic mix of 61 million tons of debris, 100,000 tons of explosives, and chemicals leaked into the earth has destroyed ...

Discover the top antivirus software solutions for Android devices in 2026, designed to protect enterprises from sophisticated mobile threats, including ransomware and phishing. Get the insights you ...

Step inside Skyroot Aerospace’s Infinity Campus in Hyderabad—the country’s first privately built rocket factory—and witness how India’s new space age is taking shape.

Mabxience And Amneal Announces FDA Approval Of Denosumab Biosimilars Referencing Prolia® And XGEVA®. mAbxience / Key word(s): Miscellaneous mAbxience and Amneal Announces FDA Approval of Denosumab ...

Detailed price information for Amneal Pharmaceuticals Inc (AMRX-Q) from The Globe and Mail including charting and trades.

Reinforcement Learning, Explainable AI, Computational Psychiatry, Antidepressant Dose Optimization, Major Depressive Disorder, Treatment Personalization, Clinical Decision Support Share and Cite: de ...